A 59-year-old on cabotegravir long-acting injections for HIV PrEP asks about alternatives due to injection fatigue. According to CDC, which PrEP options are approved in the U.S. (patient >=35 kg, not pregnant)?AOnly TDF/FTC daily oralBOnly TAF/FTC daily oral for all exposuresCTDF/FTC daily oral, TAF/FTC daily oral (not for receptive vaginal sex), and long-acting injectable agents (e.g., cabotegravir; newer options per CDC updates)DEvent-driven TDF/FTC is FDA-approved for all populations including receptive vaginal sexELenacapavir is contraindicated for PrEP in all patientsCheck my answer